TREATMENT
Real-world data show fruquintinib efficacy in Japanese patients with advanced colorectal cancerA multicentre retrospective study of 171 Japanese patients with unresectable or recurrent colorectal cancer treated with fruquintinib monotherapy evaluated real-world progression-free survival, overall survival, and safety outcomes. (ESMO Gastrointestinal Oncology)